Literature DB >> 26462124

Therapeutic HPV vaccine holds promise.

David Killock.   

Abstract

Mesh:

Substances:

Year:  2015        PMID: 26462124     DOI: 10.1038/nrclinonc.2015.180

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial.

Authors:  Cornelia L Trimble; Matthew P Morrow; Kimberly A Kraynyak; Xuefei Shen; Michael Dallas; Jian Yan; Lance Edwards; R Lamar Parker; Lynette Denny; Mary Giffear; Ami Shah Brown; Kathleen Marcozzi-Pierce; Divya Shah; Anna M Slager; Albert J Sylvester; Amir Khan; Kate E Broderick; Robert J Juba; Timothy A Herring; Jean Boyer; Jessica Lee; Niranjan Y Sardesai; David B Weiner; Mark L Bagarazzi
Journal:  Lancet       Date:  2015-09-17       Impact factor: 79.321

  1 in total
  4 in total

1.  A Genetically Modified attenuated Listeria Vaccine Expressing HPV16 E7 Kill Tumor Cells in Direct and Antigen-Specific Manner.

Authors:  Yan Yan Jia; Wei Jun Tan; Fei Fei Duan; Zhi Ming Pan; Xiang Chen; Yue Lan Yin; Xin An Jiao
Journal:  Front Cell Infect Microbiol       Date:  2017-06-29       Impact factor: 5.293

2.  HPV/E7 induces chemotherapy-mediated tumor suppression by ceramide-dependent mitophagy.

Authors:  Raquela J Thomas; Natalia Oleinik; Shanmugam Panneer Selvam; Silvia G Vaena; Mohammed Dany; Rose N Nganga; Ryan Depalma; Kyla D Baron; Jisun Kim; Zdzislaw M Szulc; Besim Ogretmen
Journal:  EMBO Mol Med       Date:  2017-08       Impact factor: 12.137

Review 3.  Trial watch: Peptide-based vaccines in anticancer therapy.

Authors:  Lucillia Bezu; Oliver Kepp; Giulia Cerrato; Jonathan Pol; Jitka Fucikova; Radek Spisek; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2018-09-06       Impact factor: 8.110

Review 4.  Lipid Nanoparticles for mRNA Delivery to Enhance Cancer Immunotherapy.

Authors:  Hong-Li Wang; Zhi-Gang Wang; Shu-Lin Liu
Journal:  Molecules       Date:  2022-08-31       Impact factor: 4.927

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.